Company nabs funds for platform using pulsating light to control cellular development.
Californian biotech startup Prolific Machines recently closed a $55 million Series B1 round for its novel technology, which leverages light to create proteins. The company will use the capital to commercialize its platform in tandem with industry partners.
The round was led by The Ki Tua Fund with…